Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Deneris, J. Boulter, L. Swanson, J. Patrick, S. Heinemann (1989)
Beta 3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain.The Journal of biological chemistry, 264 11
E. Richelson, M. Pfenning (1984)
Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.European journal of pharmacology, 104 3-4
L. Wilkins, Aaron Haubner, Joshua Ayers, P. Crooks, L. Dwoskin (2002)
N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.Journal of Pharmacology and Experimental Therapeutics, 301
S. Harvey, C. Luetje (1996)
Determinants of Competitive Antagonist Sensitivity on Neuronal Nicotinic Receptor β SubunitsThe Journal of Neuroscience, 16
J. Rose, F. Behm (2004)
Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 6 3
D. Schulz, R. Zigmond (1989)
Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatumNeuroscience Letters, 98
J. Slemmer, B. Martin, M. Damaj (2000)
Bupropion is a nicotinic antagonist.The Journal of pharmacology and experimental therapeutics, 295 1
L. Dwoskin, Peter Crooks (2001)
Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.The Journal of pharmacology and experimental therapeutics, 298 2
D. Balfour (2002)
The Neurobiology of Tobacco Dependence: A CommentaryRespiration, 69
C. Luetje, K. Wada, S. Rogers, S. Abramson, K. Tsuji, S. Heinemann, J. Patrick (1990)
Neurotoxins Distinguish Between Different Neuronal Nicotinic Acetylcholine Receptor Subunit CombinationsJournal of Neurochemistry, 55
J. Kulak, Thu Nguyen, B. Olivera, J. McIntosh (1997)
α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal SynaptosomesThe Journal of Neuroscience, 17
J. Fryer, R. Lukas (1999)
Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.The Journal of pharmacology and experimental therapeutics, 288 1
L. Azam, U. Winzer-Serhan, Yiling Chen, F. Leslie (2002)
Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neuronsJournal of Comparative Neurology, 444
G. Koob (1992)
Neural Mechanisms of Drug Reinforcement aAnnals of the New York Academy of Sciences, 654
I. Stolerman, M. Jarvis (2005)
The scientific case that nicotine is addictivePsychopharmacology, 117
D. Perry, Yingxian Xiao, Henry Nguyen, J. Musachio, M. Dávila-García, K. Kellar (2002)
Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography.Journal of neurochemistry, 82 3
Christopher Flores, Scott Rogers, L. Pabreza, B. Wolfe, K. Kellar (1992)
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.Molecular pharmacology, 41 1
G. Koob (1999)
The Role of the Striatopallidal and Extended Amygdala Systems in Drug AddictionAnnals of the New York Academy of Sciences, 877
F. Göldner, K. Dineley, J. Patrick (1997)
Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and ventral tegmental areaNeuroReport, 8
(2005)
NONI and NDNI analogs : structural modification of the N - n - alkyl moiety and the effect on neuronal nicotinic receptor activity
E. Cooper, S. Couturier, M. Ballivet (1991)
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptorNature, 350
S. Harvey, J. McIntosh, G. Cartier, F. Maddox, C. Luetje (1997)
Determinants of Specificity for α-Conotoxin MII on α3β2 Neuronal Nicotinic ReceptorsMolecular Pharmacology, 51
S. Barrett, I. Boileau, J. Okker, R. Pihl, A. Dagher (2004)
The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]racloprideSynapse, 54
J. Boorman, Paul GrootKormelink, L. Sivilotti (2000)
Stoichiometry of human recombinant neuronal nicotinic receptors containing the β3 subunit expressed in Xenopus oocytesThe Journal of Physiology, 529
P. Wileyto, F. Patterson, R. Niaura, L. Epstein, Richard Brown, J. Audrain-McGovern, L. Hawk, C. Lerman (2004)
Do small lapses predict relapse to smoking behavior under bupropion treatment?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 6 2
A. Davies, D. Hardick, I. Blagbrough, B. Potter, A. Wolstenholme, S. Wonnacott (1999)
Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptorsNeuropharmacology, 38
R. Lukas, J. Changeux, N. Novère, E. Albuquerque, D. Balfour, D. Berg, D. Bertrand, V. Chiappinelli, P. Clarke, A. Collins, J. Dani, S. Grady, K. Kellar, J. Lindstrom, M. Marks, M. Quik, P. Taylor, S. Wonnacott (1999)
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.Pharmacological reviews, 51 2
J. Lindstrom (2000)
The Structures of Neuronal Nicotinic ReceptorsHandbook of experimental pharmacology, 144
S. Wonnacott (1997)
Presynaptic nicotinic ACh receptorsTrends in Neurosciences, 20
X. Peng, Volodymyr Gerzanich, René Anand, Paul Whiting, Jon Lindstrom (1994)
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.Molecular pharmacology, 46 3
G. Cartier, D. Yoshikami, W. Gray, S. Luo, B. Olivera, J. McIntosh (1996)
A New -Conotoxin Which Targets 32 Nicotinic Acetylcholine Receptors (*)The Journal of Biological Chemistry, 271
N. Novère, J. Changeux (1995)
Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cellsJournal of Molecular Evolution, 40
T. George, S. O'Malley (2004)
Current pharmacological treatments for nicotine dependence.Trends in pharmacological sciences, 25 1
R. Papke (1993)
The kinetic properties of neuronal nicotinic receptors: Genetic basis of functional diversityProgress in Neurobiology, 41
J. Lindstrom (1996)
Neuronal nicotinic acetylcholine receptors.Ion channels, 4
R. Klink, A. d’Exaerde, M. Zoli, J. Changeux (2001)
Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic NucleiThe Journal of Neuroscience, 21
S. Kaiser, S. Wonnacott (2000)
alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.Molecular pharmacology, 58 2
Roy Wise (2000)
Addiction Becomes a Brain DiseaseNeuron, 26
M. Damaj, F. Carroll, J. Eaton, H. Navarro, B. Blough, S. Mirza, R. Lukas, B. Martin (2004)
Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic ReceptorsMolecular Pharmacology, 66
G. Nomikos, G. Damsma, D. Wenkstern, H. Fibiger (1989)
Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2 4
A. Mathieu-Kia, Kellogg Sh, E. Butelman, M. Kreek (2002)
Nicotine addiction: insights from recent animal studiesPsychopharmacology, 162
M. Picciotto, M. Zoli, R. Rimondini, C. Léna, L. Marubio, E. Pich, K. Fuxe, J. Changeux (1998)
Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotineNature, 391
Jun Zhu, P. Crooks, Joshua Ayers, Sangeetha Sumithran, L. Dwoskin (2003)
N‐n‐alkylnicotinium and N‐n‐alkylpyridinium analogs inhibit the dopamine transporter: Selectivity as nicotinic receptor antagonistsDrug Development Research, 60
M. Zoli, M. Moretti, A. Zanardi, J. Mcintosh, F. Clementi, C. Gotti (2002)
Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat StriatumThe Journal of Neuroscience, 22
K. Shima, J. Tanji (1998)
Role for cingulate motor area cells in voluntary movement selection based on reward.Science, 282 5392
Simon Li, K. Perry, D. Wong (2002)
Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of ratsNeuropharmacology, 42
M. Bradford (1976)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Analytical biochemistry, 72
F. Sgard, Eric Charpantier, S. Bertrand, N. Walker, D. Caput, D. Graham, D. Bertrand, F. Besnard (2002)
A Novel Human Nicotinic Receptor Subunit, α10, That Confers Functionality to the α9-SubunitMolecular Pharmacology, 61
R. Spanagel, F. Weiss (1999)
The dopamine hypothesis of reward: past and current statusTrends in Neurosciences, 22
J. Rose, F. Behm, E. Westman, E. Levin, R. Stein, Gail Ripka (1994)
Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment aloneClinical Pharmacology & Therapeutics, 56
S. Kaiser, L. Soliakov, Scott Harvey, C. Luetje, S. Wonnacott (1998)
Differential Inhibition by α‐Conotoxin‐MII of the Nicotinic Stimulation of [3H]Dopamine Release from Rat Striatal Synaptosomes and SlicesJournal of Neurochemistry, 70
E. Charpantier, P. Barnéoud, P. Moser, F. Besnard, F. Sgard (1998)
Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental areaNeuroReport, 9
M. Bardo (1998)
Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens.Critical reviews in neurobiology, 12 1-2
L. Dwoskin, Sangeetha Sumithran, Jun Zhu, A. Deaciuc, Joshua Ayers, Peter Crooks (2004)
Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.Bioorganic & medicinal chemistry letters, 14 8
Paul Whiting, R. Schoepfer, Jon Lindstrom, T. Priestley (1991)
Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.Molecular pharmacology, 40 4
Dennis Miller, Sangeetha Sumithran, L. Dwoskin (2002)
Bupropion Inhibits Nicotine-Evoked [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine and from Rat Hippocampal Slices Preloaded with [3H]NorepinephrineJournal of Pharmacology and Experimental Therapeutics, 302
M. Nelson, A. Kuryatov, Catherine Choi, Yan Zhou, J. Lindstrom (2003)
Alternate Stoichiometries of α4β2 Nicotinic Acetylcholine ReceptorsMolecular Pharmacology, 63
C. Gotti, F. Clementi (2004)
Neuronal nicotinic receptors: from structure to pathologyProgress in Neurobiology, 74
R. Zwart, H. Vijverberg (1998)
Four Pharmacologically Distinct Subtypes of α4β2 Nicotinic Acetylcholine Receptor Expressed in Xenopus laevisOocytesMolecular Pharmacology, 54
N. Novère, M. Zoli, J. Changeux (1996)
Neuronal Nicotinic Receptor a6 Subunit mRNA is Selectively Concentrated in Catecholaminergic Nuclei of the Rat BrainEuropean Journal of Neuroscience, 8
J. McIntosh, L. Azam, Sarah Staheli, Cheryl Dowell, Jon Lindstrom, A. Kuryatov, James Garrett, Michael Marks, P. Whiteaker (2004)
Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptorsMolecular Pharmacology, 65
Yung‐chi Cheng, W. Prusoff (1973)
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.Biochemical pharmacology, 22 23
J. Ramírez-Latorre, C. Yu, Xiaoyan Qu, F. Périn, Arthur Karlin, Lorna Role (1996)
Functional contributions of α5 subunit to neuronal acetylcholine receptor channelsNature, 380
D. McGehee, M. Heath, S. Gelber, P. Dévay, L. Role (1995)
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.Science, 269 5231
J. Ascher, J. Cole, J. Colin, J. Feighner, R. Ferris, H. Fibiger, R. Golden, P. Martin, W. Potter, E. Richelson (1995)
Bupropion: a review of its mechanism of antidepressant activity.The Journal of clinical psychiatry, 56 9
O. Salminen, Karen Murphy, Karen Murphy, J. McIntosh, J. Drago, M. Marks, A. Collins, S. Grady (2004)
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.Molecular pharmacology, 65 6
S. Grady, M. Marks, S. Wonnacott, A. Collins (1992)
Characterization of Nicotinic Receptor‐Mediated [3H]Dopamine Release from Synaptosomes Prepared from Mouse StriatumJournal of Neurochemistry, 59
S. Grady, Karen Murphy, J. Cao, M. Marks, J. McIntosh, A. Collins (2002)
Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.The Journal of pharmacology and experimental therapeutics, 301 2
(1998)
What is the role of dopamine in reward : hedonic impact , reward learning , or incentive salience ?
R. Hurt, J. Krook, I. Croghan, C. Loprinzi, J. Sloan, P. Novotny, C. Kardinal, J. Knost, M. Tirona, F. Addo, R. Morton, J. Michalak, P. Schaefer, Patricia Porter, P. Stella (2003)
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 5
L. Wilkins, V. Grinevich, Joshua Ayers, P. Crooks, L. Dwoskin (2003)
N-n-Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with α4β2* and α7* Neuronal Nicotinic ReceptorsJournal of Pharmacology and Experimental Therapeutics, 304
M. Parker, A. Beck, C. Luetje (1998)
Neuronal Nicotinic Receptor β2 and β4 Subunits Confer Large Differences in Agonist Binding AffinityMolecular Pharmacology, 54
P. Whiteaker, Cyrus Peterson, W. Xu, J. McIntosh, R. Paylor, A. Beaudet, A. Collins, M. Marks (2002)
Involvement of the α3 Subunit in Central Nicotinic Binding PopulationsThe Journal of Neuroscience, 22
Gretchen López-Hernández, Javier Sánchez-Padilla, A. Ortiz-Acevedo, José Lizardi-Ortiz, Janice Salas-Vincenty, L. Rojas, J. Lasalde-Dominicci (2004)
Nicotine-induced Up-regulation and Desensitization of α4β2 Neuronal Nicotinic Receptors Depend on Subunit Ratio*Journal of Biological Chemistry, 279
E. Stein, J. Pankiewicz, H. Harsch, Jung-Ki Cho, S. Fuller, Ray Hoffmann, M. Hawkins, S. Rao, P. Bandettini, A. Bloom (1998)
Nicotine-induced limbic cortical activation in the human brain: a functional MRI study.The American journal of psychiatry, 155 8
G. Chiara (2000)
Role of dopamine in the behavioural actions of nicotine related to addiction.European Journal of Pharmacology, 393
R. Anand, W. Conroy, R. Schoepfer, P. Whiting, J. Lindstrom (1991)
Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure.The Journal of biological chemistry, 266 17
E. Wada, K. Wada, J. Boulter, E. Deneris, S. Heinemann, J. Patrick, L. Swanson (1989)
Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the ratJournal of Comparative Neurology, 284
R. Wise, M. Bozarth (1987)
A psychomotor stimulant theory of addiction.Psychological review, 94 4
A. Kuryatov, F. Olale, J. Cooper, C. Choi, J. Lindstrom (2000)
Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responsesNeuropharmacology, 39
D. Perry, Yingxian Xiao, Henry Nguyen, J. Musachio, M. Dávila-García, K. Kellar (2002)
Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiographyJournal of Neurochemistry, 82
S. Grady, Natalie Meinerz, J. Cao, Andrew Reynolds, M. Picciotto, J. Changeux, J. McIntosh, M. Marks, A. Collins (2001)
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatumJournal of Neurochemistry, 76
Fernanda Gumilar, H. Arias, G. Spitzmaul, C. Bouzat (2003)
Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressantsNeuropharmacology, 45
L. Dwoskin, R. Xu, Joshua Ayers, P. Crooks (2000)
Recent developments in neuronal nicotinic acetylcholine receptor antagonistsExpert Opinion on Therapeutic Patents, 10
G. Chiara, V. Bassareo, S. Fenu, M. Luca, L. Spina, C. Cadoni, E. Acquas, E. Carboni, V. Valentini, D. Lecca (2004)
Dopamine and drug addiction: the nucleus accumbens shell connectionNeuropharmacology, 47
Role of catecholamine transmitters in brain reward systems
J. Rose, E. Westman, F. Behm, Mark Johnson, J. Goldberg (1999)
Blockade of Smoking Satisfaction Using the Peripheral Nicotinic Antagonist TrimethaphanPharmacology Biochemistry and Behavior, 62
A. Elgoyhen, D. Vetter, E. Katz, C. Rothlin, S. Heinemann, J. Boulter (2001)
α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cellsProceedings of the National Academy of Sciences of the United States of America, 98
P. Crooks, A. Ravard, L. Wilkins, L. Teng, S. Buxton, L. Dwoskin (1995)
Inhibition of nicotine‐evoked [3H] dopamine release by pyridino N‐substituted nicotine analogues: A new class of nicotinic antagonistDrug Development Research, 36
P. Clarke (2004)
Nicotine and smoking: a perspective from animal studiesPsychopharmacology, 92
C. Luetje, J. Patrick (1991)
Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors, 11
Changhai Cui, T. Booker, R. Allen, S. Grady, P. Whiteaker, M. Marks, O. Salminen, T. Tritto, C. Butt, W. Allen, J. Stitzel, J. McIntosh, J. Boulter, A. Collins, S. Heinemann (2003)
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related BehaviorsThe Journal of Neuroscience, 23
N. Champtiaux, C. Gotti, M. Cordero-Erausquin, D. David, C. Przybylski, C. Léna, F. Clementi, M. Moretti, F. Rossi, N. Novère, J. McIntosh, A. Gardier, J. Changeux (2003)
Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out MiceThe Journal of Neuroscience, 23
P. Whiteaker, M. Marks, S. Grady, Y. Lu, M. Picciotto, J. Changeux, A. Collins (2000)
Pharmacological and null mutation approaches reveal nicotinic receptor diversity.European journal of pharmacology, 393 1-3
C. Luetje (2004)
Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release.Molecular pharmacology, 65 6
C. Pomerleau, O. Pomerleau (2005)
Euphoriant effects of nicotine in smokersPsychopharmacology, 108
Dennis Miller, P. Crooks, L. Dwoskin (2000)
Lobeline inhibits nicotine-evoked [3H]dopamine overflow from rat striatal slices and nicotine-evoked 86Rb+ efflux from thalamic synaptosomesNeuropharmacology, 39
N. Champtiaux, Zhi-yan Han, A. Bessis, F. Rossi, Michele Zoli, Michele Zoli, L. Marubio, J. McIntosh, J. Changeux (2002)
Distribution and Pharmacology of α6-Containing Nicotinic Acetylcholine Receptors Analyzed with Mutant MiceThe Journal of Neuroscience, 22
H. Mansvelder, D. McGehee (2002)
Cellular and synaptic mechanisms of nicotine addiction.Journal of neurobiology, 53 4
A. Brody, M. Mandelkern, Grace Lee, Erlyn Smith, Mary Sadeghi, S. Saxena, M. Jarvik, E. London (2004)
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary studyPsychiatry Research: Neuroimaging, 130
F. Pontieri, G. Tanda, F. Orzi, G. Chiara (1996)
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugsNature, 382
D. McGehee, L. Role (1995)
Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.Annual review of physiology, 57
J. Irvin, P. Hendricks, T. Brandon (2003)
The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 5 1
Chantal Martin-Soelch, K. Leenders, A. Chevalley, J. Missimer, G. Kunig, S. Magyar, A. Mino, Willibrordus Schultz (2001)
Reward mechanisms in the brain and their role in dependence: evidence from neurophysiological and neuroimaging studiesBrain Research Reviews, 36
L. Teng, P. Crooks, S. Buxton, L. Dwoskin (1997)
Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.The Journal of pharmacology and experimental therapeutics, 283 2
W. Corrigall, K. Franklin, K. Coen, P. Clarke (2005)
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotinePsychopharmacology, 107
N-n-Octylnicotinium iodide (NONI) andN-n-decylnicotinium iodide (NDNI) are selective nicotinic receptor (nAChR) antagonists mediating nicotine-evoked striatal dopamine (DA) release, and inhibiting [3H]nicotine binding, respectively. This study evaluated effects of introducing unsaturation into theN-n-alkyl chains of NONI and NDNI on inhibition of [3H]nicotine and [3H]methyllycaconitine binding (α4β2* and α7* nAChRs, respectively),86Rb+ efflux and [3H]DA release (agonist or antagonist effects at α4β2* and α6β2*-containing nAChRs, respectively). In the NONI series, introduction of a C3-cis-(NONB3c), C3-trans-(NONB3t), C7-double-bond (NONB7e), or C3-triple-bond (NONB3y) afforded a 4-fold to 250-fold increased affinity for [3H]nicotine binding sites compared with NONI. NONB7e and NONB3y inhibited nicotine-evoked86Rb+ efflux, indicating α4β2* antagonism. NONI analogs exhibited a 3-fold to 8-fold greater potency inhibiting nicotine-evoked [3H]DA overflow compared with NONI (IC50=0.62 μM; Imax=89%), with no change in Imax, except for NONB3y (Imax=50%). In the NDNI series, introduction of a C4-cis-(NDNB4c), C4-trans-double-bond (NDNB4t), or C3-triple-bond (NDNB3y) afforded a 4-fold to 80-fold decreased affinity for [3H]nicotine binding sites compared with NDNI, whereas introduction of a C9-double-bond (NDNB9e) did not alter affinity. NDNB3y and NDNB4t inhibited nicotine-evoked86Rb+ efflux, indicating anatogonism at α4β2* nAChRs. Although NDNI had no effect, NDNB4t and NDNB9e potently inhibited nicotine-evoked [3H]DA overflow (IC50=0.02–0.14μM, Imax=90%), as did NDNB4c (IC50=0.08 μM; Imax=50%), whereas NDNB3y showed no inhibition. None of the analogs had significant affinity for α7* nAChRs. Thus, unsaturated NONI analogs had enhanced affinity at α4β2*-and α6β2*-containing nAChRs, however a general reduction of affinity at α4β2* and an uncovering of antagonist effects at α6β2*-containing nAChRs were observed with unsaturated NDNI analogs.
"The AAPS Journal" – Springer Journals
Published: Mar 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.